Sophiris Bio Inc. News
Sophiris Bio (SPHS) Stock Coverage Initiated at Roth Capital
Roth Capital initiated coverage of Sophiris Bio (SPHS) stock with a 'buy' rating on Thursday.
Sophiris Bio (SPHS) Stock Tumbles on Public Offering
Sophiris Bio (SPHS) announced an offering of common shares and warrants late on Monday.
Sophiris Bio (SPHS) Stock Jumps After Drug Trial Meets Goal
Sophiris Bio (SPHS) stock is increasing on heavy trading volume on Wednesday, after the company announced that its prostate drug met the goal of a Phase 3 study.
5 Stocks Poised for Big Breakouts: Xoom, Alcobra and More
These stocks look ready to break out and trade higher from current levels.
4 Biotech Stocks Under $10 to Trade for Breakouts: Sophiris, Atossa and More
Keep these under-$10 biotech stocks on your breakout trading radar.
3 Under-$10 Health Care Stocks Triggering Breakout Trades
Keep these health care stocks under $10 on your breakout trading radar.
Tesla Chart Faces Key Hurdle. Here's What Happens If It Fails.
Tesla stock faces a key hurdle on the charts. Here's what happens if resistance rejects it.
Tim Cook and Apple Make a Move That Could Annoy China
iPhone maker wants to diversify its supply chain and expand in a crucial market.